Constantina Chrysochou

Serum Phosphate and Mortality in Patients with Chronic Kidney Disease

Helen Eddington, Richard Hoefield, Smeeta Sinha et al. · Clinical Journal of the American Society of Nephrology · 2010 · 236 citations · Full text

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

High-Risk Clinical Presentations in Atherosclerotic Renovascular Disease: Prognosis and Response to Renal Artery Revascularization

James Ritchie, Darren Green, Constantina Chrysochou et al. · American Journal of Kidney Diseases · 2013 · 191 citations

High-risk Clinical Presentations, Vascular Disease, Urology +11

Dispelling the myth: the use of renin-angiotensin blockade in atheromatous renovascular disease

Constantina Chrysochou, Robert N. Foley, John F. Young et al. · Nephrology Dialysis Transplantation · 2011 · 120 citations · Full text